Los agonistas del receptor GLP-1 (pptido similar al glucagn tipo 1), como semaglutida (Ozempic, Wegovy) y liraglutida (Victoza, Saxenda), se prescriben para indicaciones especficas: Ozempic y Victoza para diabetes tipo 2, mientras que Wegovy y Saxenda estn aprobados para el control de peso crnico
The separation between platform and prescriber is a structural feature of how legal telehealth companies operate, not a technicality
Studies suggest BPC-157 works as a signaling moleculea messenger that influences how cells behave, especially in the presence of injury, inflammation, or imbalance
To fully understand the role of GLP-1RAs in managing diabetes and depression, further randomized controlled trials and long-term studies are needed, Guo added